Rik Lindeboom's thesis describes fundamental research into gene regulation in embryonic development, stem cell differentiation and cancer.  Rik Lindeboom has used a multi-omics strategy and big data 'omics' analyses, resulting in an original combination of excellent computational and innovative experimental research. By integrating multi-omics datasets of multiple model systems and diseases, his work gave many new insights into the global understanding of how gene regulation is orchestrated at a system-wide level. Rik Lindenboom completed his PhD with honors and currently works as a PostDoc at the Wellcome Sanger Institute in Cambridge, UK.

The prize will be handed out during the NVBMB spring symposium in 2022.